Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Rev. méd. Chile ; 133(6): 667-673, jun. 2005. graf
Artigo em Espanhol | LILACS | ID: lil-429121

RESUMO

Background: Erectile dysfunction is a public health problem. Millions of men worldwide experience this condition, affecting their quality of life. Sildenafil, a phosphodiesterase type 5 inhibitor, is the treatment of choice for erectile dysfunction. Aim: To study the characteristics of Sildenafil use among costumers of community pharmacies in Concepcion Chile. Material and methods: A structured interview about Sildenafil use was applied to subjects purchasing the drug in community pharmacies and that consented to participate. Results: One hundred thirty eight males were studied. Forty six percent of patients were fifty years old or older. Most (47.1%) used Sildenafil for one year or more and 60.5% had no adverse events. Among those experiencing side effects, headache was experienced by 38.9%, flushing by 16.6% and gastrointestinal effects by 16.7%. Ninety percent of patients had a good evaluation of the drug in terms of benefits and tolerance. Thirty two percent of the subjects, had diseases associated to erectile dysfunction. Among these, 45% had diabetes mellitus, 29.5% had hypertension, and 18.2% had prostatic diseases. In 54% of cases, the drug was prescribed by a physician. Twenty two percent of patients experienced changes in the effect of the drug when it was simultaneously used with other drugs or meals. Thirty four percent of patients used other drugs. Among these, 43.3% were using antihypertensives, and 26.7% were using antidiabetic drugs. Conclusions: Considering the elevated age and the number of associated disease of patients using Sildenafil, the use of the drug under medical prescription must be emphasized to avoid untoward effects.


Assuntos
Adulto , Humanos , Masculino , Pessoa de Meia-Idade , Disfunção Erétil/tratamento farmacológico , Inibidores de Fosfodiesterase/uso terapêutico , Piperazinas/uso terapêutico , Vasodilatadores/uso terapêutico , Fatores Etários , Chile , Serviços Comunitários de Farmácia , Interações Medicamentosas , Disfunção Erétil/etiologia , Entrevistas como Assunto , Inibidores de Fosfodiesterase/efeitos adversos , Piperazinas/efeitos adversos , Polimedicação , Purinas , Fatores de Risco , Sulfonas , Vasodilatadores/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA